Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2453102rdf:typepubmed:Citationlld:pubmed
pubmed-article:2453102lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C0178665lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C0069698lld:lifeskim
pubmed-article:2453102lifeskim:mentionsumls-concept:C0733742lld:lifeskim
pubmed-article:2453102pubmed:issue4lld:pubmed
pubmed-article:2453102pubmed:dateCreated1988-6-13lld:pubmed
pubmed-article:2453102pubmed:abstractTextThe influence of two kinds of contraceptive pills, a sequential one and a combined one (Sequenz-Ovosiston and Minisiston), on serum lipoproteins and carbohydrate metabolism was investigated in 32 young patients who got these drugs for the first time during a period of 12 months. There were no pathological values of cholesterol, high density proteins, low density proteins, triglycerides or oral glucose tolerance test during and after the treatment. The authors summarized, that neither Sequenz-Ovosiston nor Minisiston increase the risk of atherosclerosis and of diabetes in young healthy women.lld:pubmed
pubmed-article:2453102pubmed:languagegerlld:pubmed
pubmed-article:2453102pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:citationSubsetIMlld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2453102pubmed:statusMEDLINElld:pubmed
pubmed-article:2453102pubmed:issn0044-4197lld:pubmed
pubmed-article:2453102pubmed:authorpubmed-author:VesperV BVBlld:pubmed
pubmed-article:2453102pubmed:authorpubmed-author:FeustelSSlld:pubmed
pubmed-article:2453102pubmed:issnTypePrintlld:pubmed
pubmed-article:2453102pubmed:volume110lld:pubmed
pubmed-article:2453102pubmed:ownerNLMlld:pubmed
pubmed-article:2453102pubmed:authorsCompleteYlld:pubmed
pubmed-article:2453102pubmed:pagination241-5lld:pubmed
pubmed-article:2453102pubmed:dateRevised2008-2-11lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:meshHeadingpubmed-meshheading:2453102-...lld:pubmed
pubmed-article:2453102pubmed:year1988lld:pubmed
pubmed-article:2453102pubmed:articleTitle[Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].lld:pubmed
pubmed-article:2453102pubmed:affiliationKlinik und Poliklinik für Gynäkologie und Geburtshilfe, Bereichs Medizin (Charité) der Humboldt-Universität.lld:pubmed
pubmed-article:2453102pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2453102pubmed:publicationTypeEnglish Abstractlld:pubmed